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Background: The ability of S. pneumoniae to generate infections depends on the restrictions imposed by the host’s
immunity, in order to prevent the bacterium from spreading from the nasopharynx to other tissues, such as the brain.
Some authors claim that strains of S. pneumoniae, which fail to survive in the bloodstream, can enter the brain directly from
the nasal cavity by axonal transport through the olfactory and/or trigeminal nerves. However, from the immunological
point of view, glial cells are far more responsive to bacterial infections than are neurons. This hypothesis is consistent with
several recent reports showing that bacteria can infect glial cells from the olfactory bulb and trigeminal ganglia. Since our
group previously demonstrated that Schwann cells (SCs) express a functional and appropriately regulated mannose
receptor (MR), we decided to test whether SCs are involved in the internalization of S. pneumoniae via MR.
Results: Immediately after the interaction step, as well as 3 h later, the percentage of association was approximately
56.5%, decreasing to 47.2% and 40.8% after 12 and 24 h, respectively. Competition assays by adding a 100-fold excess
of mannan prior to the S. pneumoniae infection reduced the number of infected cells at 3 and 24 h. A cytochemistry
assay with Man/BSA-FITC binding was performed in order to verify a possible overlap between mannosylated ligands
and internalized bacteria. Incubation of the SCs with Man/BSA-FITC resulted in a large number of intracellular S. pneumoniae,
with nearly complete loss of the capsule. Moreover, the anti-pneumococcal antiserum staining colocalized with the
internalized man/BSA-FITC, suggesting that both markers are present within the same endocytic compartment of the SC.
Conclusions: Our data offer novel evidence that SCs could be essential for pneumococcal cells to escape phagocytosis
and killing by innate immune cells. On the other hand, the results also support the idea that SCs are
immunocompetent cells of the PNS that can mediate an efficient immune response against pathogens via MR.
Keywords: Pneumococcal meningitis, Glia, Pattern recognition receptor (PRRs), Innate immunity, Pathogen-associated
molecular patterns (PAMPs), Nerve injuryBackground
Streptococcus pneumoniae is a Gram-positive bacterial
pathogen that commonly colonizes the human respira-
tory tract. The ability of S. pneumoniae to generate in-
fections depends on the restrictions imposed by the
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article, unless otherwise stated.nasopharynx to other tissues and sites, such as the mid-
dle ear, lungs, blood, and brain [1]. The means by which
some strains of S. pneumoniae invade the brain without
the occurrence of bacteremia are still unknown. Some
authors claim that strains of S. pneumoniae, failing to
survive in the bloodstream, can enter the Central Ner-
vous System (CNS) directly from the nasal cavity by
axonal transport through the olfactory nerves or trigemi-
nal ganglia [2]. However, from the immunological point
of view, glial cells are far more responsive to bacterial in-
fections than are neurons, and therefore more likely toCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Macedo-Ramos et al. BMC Microbiology 2014, 14:211 Page 2 of 9
http://www.biomedcentral.com/1471-2180/14/211internalize them. This hypothesis is consistent with sev-
eral recent reports showing that bacteria can infect glial
cells from the olfactory bulb and trigeminal ganglia, such
as Olfactory Ensheathing Cells (OECs) and Schwann
cells (SCs), respectively [3-5].
SCs are glial cells that are closely associated with the
peripheral nerves, and can be classified into two types:
myelinating and non-myelinating. Myelinating Schwann
cells provide the myelin sheath of individual axons, and
non-myelinating Schwann cells ensheathe several small
axons. Both SC phenotypes can interface with the exter-
nal environment through nerve endings scattered in the
mucosa, and thus can potentially interact with pathogens.
Several lines of evidence suggest that SCs can function as
sentinel cells in the peripheral nervous system (PNS), and
are a potent source of cytokines and innate immune re-
ceptors (pattern recognition receptors [PRRs]), such as
Toll-like receptors (TLRs) and Mannose Receptors (MR),
which are capable of controlling adaptive immune re-
sponses against self- and non-self antigens [6-9].
MR is a 175-kDa transmembrane glycoprotein recep-
tor that contains multiple domains in the extracellular
region, including Ca2+-dependent lectin-like carbohy-
drate recognition (CTLD), responsible for the binding to
mannose, fucose, and N-acetylglucosamine, present in
small molecular motifs called pathogen-associated mo-
lecular patterns (PAMPs) and damage-associated mo-
lecular patterns (DAMPs) [10-12]. MR has emerged as
an important component of the innate immune system,
participating in host defense following microbial infec-
tions. This receptor can initiate host mechanisms to re-
move pathogens, most specifically through activated
macrophages. However, other cell types express MR in a
functional state able to recognize and internalize micro-
bial components [13]. MR is involved in the innate im-
mune response in several tissues [14,15], including
normal and injured nerve tissue, where it was found to ex-
press in microglia, astrocytes, immature neurons, Schwann
cells, and olfactory ensheathing cells [16,7,3,17,18]. How-
ever, there is no evidence that either mature oligodendro-
cytes or their precursors express MR [19].
By using different models of interaction with some
highly mannosylated ligands, our group previously dem-
onstrated that SCs express a functional and appropriately
regulated MR [20,7]. We also demonstrated that SCs may
harbor infectious agents and act as safe hosts by produ-
cing immune mediators [21,22]. In the present study, we
evaluated whether SCs cultured from the adult sciatic
nerve are able to internalize S. pneumoniae via RM.
Methods
Animals
One-month-old Wistar rats were used to obtain primary
SC cultures. Animal care and euthanasia proceduresfollowed the norms established by the Brazilian Society
for Neuroscience (SBNeC), as well as by the ethics com-
mittees of the Institute of Biophysics Carlos Chagas
Filho of the Federal University of Rio de Janeiro (IBCCF/
UFRJ - Permit Number: 158).
Schwann cell cultures
Primary rat SCs were obtained according to a modifica-
tion by P.M. Wood of the procedure described by
Morrissey et al. [23]. Briefly, sciatic nerves were harvested
in Leibovitz’s L 15 Medium (Invitrogen, Carlsbad, CA,
USA), fragmented, and cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM; Invitrogen) containing 10%
heat-inactivated fetal calf serum (FCS; Cultilab, Campinas,
Brazil).
After 30 days, the nerve fragments were treated with
0.5 mg/ml collagenase type I (Worthington Biochemicals,
New Jersey, NJ, USA) and 1 mg/ml dispase II (Roche
Molecular Biochemicals, Indianapolis, IN, USA) over-
night in a CO2 incubator at 37°C for dissociation. After
washing, the cells were cultured in dishes covered with
a solution containing poly-L-lysine (200 μg/ml, Sigma
Chemical, St. Louis, MO, USA), in DMEM containing
10% FCS, 100 U/ml penicillin (Invitrogen), 100 μg/ml
streptomycin (Invitrogen), 2 μM forskolin (Calbiochem,
La Jolla, CA, USA), and 20 μg/ml bovine pituitary extract
(Biomedical Technologies, Stoughton, MA, USA). After
the first passage, SCs were further selected from fibro-
blasts by using an anti-mouse Thy 1.1 antibody (undiluted
hybridoma culture supernatant, American Tissue Culture
Collection, Manassas, VA, USA) and rabbit complement
(Sigma). This resulted in approximately 97 - 99% pure SC
cultures as assessed by S100-β (DAKO, Carpinteria, CA,
USA) immunoreactivity. SC-enriched cultures were main-
tained in a humidified air/CO2 (95%/5%) atmosphere at
37°C.
Because a limited amount of primary SCs was avail-
able, pilot experiments were performed with the ST88-
14 tumor cell line (Schwannoma cells). The ST88-14
cells, isolated from a patient with neurofibromatosis type
1 [24], were kindly donated by J.A. Flechter (Dana-Farber
Cancer Institute, Boston, MA, USA). For inclusion in the
present study, the cells were grown in RPMI 1640
medium supplemented with 5% FCS, 1 mM glutamine,
1000 U/ml penicillin, and 50 μg/ml streptomycin. All
chemicals were from Sigma. The cells, plated in culture
dishes or on cover slips in 24-well plates (Falcon, Franklin
Lakes, NJ, USA), were maintained in a humidified air/CO2
(95%/5%) atmosphere at 37°C for 24 h.
Phenotypic identification of SCs
The SCs cultures, both ST88-14 cells and Schwann cell
primary cultures, were treated with PBS + 0.3% Triton
X-100 (Sigma) and blocked with 10% normal goat serum
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were incubated with mouse monoclonal antibody anti-
S100-β (Sigma), a Schwann cell marker [25]. After reac-
tion with the primary antibodies of interest, cells were in-
cubated with goat anti-rabbit IgG and/or goat anti-mouse
IgG secondary antibodies. Soon after, the cells were
washed in PBS pH 7.4 and mounted with N-propylgallate
in PBS-glycerol and coverslipped.
Expression of MR and uptake of a mannosylated
neoglycoprotein by SCs
SCs were tested for the expression of MR by labeling
with a polyclonal antibody, produced in rabbits, directed
against a C-terminal peptide of murine MR (anti-cMR,
1/100), kindly donated by Dr. Anne Régnier-Vigouroux
[19]. A cytochemistry assay with 50 μg/ml of the neoglyco-
protein mannosyl/bovine serum albumin-FITC-conjugated
(man/BSA-FITC, Sigma) diluted in Ringer solution con-
taining 5 mM CaCl2 and 1% BSA at 37°C for 1 h was
performed in order to confirm the internalization pat-
tern in SCs. Both expression and functional analyses
(MR-mediated endocytosis) of the MR in SCs were per-
formed as previously described by us in detail [20,7].
Interaction assay of S. pneumoniae and SCs
Strain S. pneumoniae ATCC 49619 (American Type Culture
Collection 49619) was selected for performing interaction
assays with SCs, based on the facts that (1) it is a reference
strain widely used in medical microbiology research and
diagnostic laboratories worldwide; and (2) it belongs to sero-
type 19 F, which is frequently associated with pneumococcal
infections in many parts of the world and is often linked to
resistance to penicillin and other antimicrobial agents [26].
For interaction assays, bacterial cells were obtained by
streaking strain ATCC 49619 on 5% sheep blood agar
plates (Plast Labor, Rio de Janeiro, RJ, Brazil). After incu-
bation at 37°C for 20 h under 5% CO2 atmosphere, indi-
vidual colonies were selected and cells were suspended
in Hanks' balanced salt solution (HBSS; Sigma) to reach
a turbidity equivalent to the 0.5 McFarland standard.
To reduce cell clumping, the bacterial suspension was
passed 15 times through a 27-gauge needle and then
allowed to settle for 15 min. Only the top fraction of
the suspension containing dispersed bacteria was used
to infect SCs. This dissociation method was used only
in the case of bacterial clumping.
First, we determined the number of SCs using a Neu-
bauer Chamber. Next, the bacterial inoculum was deter-
mined by McFarland Turbidity Standards. SC cultures
were infected with suspensions of living S. pneumoniae
ATCC 49619 cells in a ratio of 100:1 bacteria/SC cells for
at least 3 h in serum- and antibiotic-free DMEM F-12.
After this period, the cultures were rinsed with PBS to re-
move non-adhered bacteria, DMEM F-12 was added, andthe infection was followed at 37°C for up to 24 h, with fix-
ation of infected cells at 3, 12, and 24 h after PBS rinsing.
The number of SCs associated with S. pneumoniae was
determined after 3, 12 and 24 h.
For the dark-field microscopy analyses, the infected and
uninfected cultures were washed in PBS and fixed. The sam-
ples on cover slips, previously fixed in 4% paraformaldehyde
at room temperature, were permeabilized with PBS-Triton
0.3% and blocked with 10% NGS [27,3]. After that, bacteria
were detected by using a Pneumococcal anti-serum (OMNI
States Serum Institut, Copenhagen, Denmark) and/or
stained with 0.1 mg/ml 4’,6-diamidino-phenylindole
(DAPI, Sigma). The viability of the bacteria was exam-
ined using fluorescent microscopy after staining with
5 mM SYTOX Green nucleic acid stain (Invitrogen) [28].
Competition assays were performed by infecting
cultures in the presence of 100 μg/ml of mannan
(hyper-mannosylated glycoprotein from Saccharomy-
ces cerevisiae - Sigma) after testing concentrations in the
range of 10 to 1000 μg/ml (10, 100, 500, and 1000 μg/ml)
[29,30,3] for 3 to 24 h. A cytochemical assay with (Man/
BSA-FITC) binding was performed in order to determine
the presence of a MR with the active CTLDs. Other in-
fected cultures were incubated with 50 μg/ml man/BSA-
FITC as described above. The glass coverslips were then
removed from each well and mounted on glass slides with
entellan glue plus 90% glycerol in PBS containing 1 μg/ml
p-phenylenediamine [27]. Samples were analyzed using
a Zeiss epifluorescence photomicroscope (Zeiss, Jena,
Germany) and a set of 200 cells was examined for the
presence of S. pneumoniae. In addition, the percentage
of cells with associated bacteria (adhered or internal-
ized) was calculated as follows: number of infected
cells/200 cells × 100.
Confocal microscopy
Cells were seeded at a density of 1.2 × 106 cells/ml in
DMEM F-12 medium plus 10% FCS on poly-L-lysine plus
laminin-coated glass coverslips for 30 min at 37°C and
mounted in N-propylgallate (Sigma) in PBS-glycerol. The
samples were placed under a Leica TCS SP5 confocal
microscope (Leica Microsystems, Heidelberg, Germany)
and all images were acquired with a 63X glycerol
immersion objective lens. Image treatment was performed
using the Image Processing Leica Confocal and ImageJ
Software (Wayne Rasband, National Institutes of Health,
Bethesda, MD, USA). The three-dimensional sections per-
pendicular to the plane of the monolayer and parallel to
the x or y axis were reconstructed using Leica Application
Suite Advanced Fluorescence (LAS AF) software.
Statistical analysis
Statistical analyses of the data from assays of competi-
tion and of cell/bacteria association were performed with
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tiple comparisons. In case of single comparisons, the
Student t test was applied. P values equal to or less than
0.05 were considered statistically significant.
Results and discussion
The present study is focused on the interaction between
S. pneumoniae, a major agent of bacterial meningitis,
and glial cells, which are currently considered as part of
the innate immune system, forming a first line of
defense against infections of the nervous system. We used
a model of infection of glial cells by S. pneumoniae. This
model was improved during previous studies by our
group, which showed that the bacterial load and time
course of infection are crucial in this in vitro model [3].
Recent studies have shown that glial cells are highly
reactive to pathogens, through regulating inflammation,
and participating in innate and adaptive immunity
[5,31-34]. In the specific case of SCs, it has been shown
that, similarly to microglia in the brain, they may act as
sentinel cells in the PNS and thus orchestrate the induc-
tion of a host defense response [35,8]. Recent data from
our group indicate that SCs from the rat sciatic nerve and
a human SC line (ST88-14) express MR in a functional
state capable of internalizing mannosylated ligand [20,7].
We also have previously shown that cells egress from sci-
atic nerve explant cultures treated with IFN-γ, MHC class
II staining colocalized with internalized neoglycoprotein
in perinuclear areas of cells phenotypically identified as
SC [7]. These findings are consistent with a possible role
of SC in the clearance of DAMPs and PAMPs, acting as
facultative antigen-presenting cells during inflammation.
Furthermore, we have previously demonstrated that a hu-
man SC line (ST88-14 cells) is able to internalize promas-
tigote forms of Leishmania amazonensis and that, in
subsequent steps to infection, the parasite triggers cellular
signal transduction pathways, inducing the nuclear trans-
location of the nuclear factor-kappa B (NF-kappa B) [21].
The ST88-14 SC line is a good model for the present
study because these cells express some phenotypic markers
of normal SCs [36]. In view of this and because a limited
amount of primary SCs and an overwhelming quantity of
ST88-14 cells were available, the pilot experiments were
performed with ST88-14 cells. After standardization of the
protocols, the same tests were repeated with primary SCs.
No significant differences were observed between the two
cell types in any of the experiments. To confirm the
Schwann-like nature of our ST88-14 cells and the purity of
the SC preparation obtained from primary cultures, both
cultures were incubated with polyclonal anti-S100-β anti-
body. All or virtually all ST88-14 cells showed marked
positivity for S100β protein (not shown). Correlative mi-
croscopy of images obtained in phase-contrast and con-
focal immunofluorescence optics showed S100-β+ cells,and revealed a high degree of purity in our primary SC cul-
tures (Figure 1B). The purity of isolated primary SCs
exceeded 97 - 99%, as previously described by our group
[7]. Incubation of fixed SCs with the cMR antibody re-
sulted in distinct labeling, widely distributed both on the
surface and in the cytoplasmic domain (different optic
planes selected from z-series) of SC from primary nerve
cultures (Figure 1C), confirming our previous data [7].
Omission of the primary antibodies eliminated the respect-
ive labeling (not shown). In an initial approach, we evalu-
ated whether SCs could harbor S. pneumoniae in an
in vitro model of infection. Our results revealed a variable
number of internalized bacteria throughout the cytoplasm
of SCs (Figure 1A). To confirm that the MR was involved
in the uptake of S. pneumoniae, SCs were reacted with
anti-cMR. In order to solve the problem caused by the use
of two antibodies produced in rabbits, the bacteria were re-
vealed with DAPI. These results showed an intense immu-
noreaction with anti-cMR in intracellular compartments
containing S. pneumoniae (Figure 1D) of SCs previously
identified by the anti-S100-β antibody (Figure 1A).
To monitor the course of infection, the number of SCs
containing adhered and/or internalized S. pneumoniae
was quantified at different times up to 24 h. Immediately
after the interaction step, as well as 3 h later, the percent-
age of association was 56.5%, and decreased to 47.2% and
40.8% after 12 and 24 h, respectively (Figure 2).
We evaluated the endocytosis of S. pneumoniae by
SCs, maintained either in medium alone or in medium
containing an excess of mannan, according to a protocol
previously described by us for the endocytosis of S.
pneumoniae by OECs [3]. Observations were made after
interaction of S. pneumoniae with SCs for 3, 12, and
24 h in both conditions. Variable numbers of internalized
bacteria as detected by labeling with anti-pneumococcal
antiserum and counterstained with DAPI were seen
throughout the cytoplasm of SCs maintained in medium
alone (Figure 3, detailed in Figure 4A-E). On the other
hand, the interaction assays performed in the presence of
mannan impaired the bacterial binding to the cellular sur-
faces, thus drastically reducing the number of infected
cells after 3 h of association (Figure 3). However, the num-
ber of infected cells was not significantly affected from 3
to 24 h of infection in the mannan-treated cultures
(Figure 3).
The results of the present study suggest that MR is in-
volved in infection of SCs by S. pneumoniae in a specific
manner. Competition assays conducted by adding a 100-
fold excess of mannan prior to the infection with S.
pneumoniae, confirmed the participation of MR during
the association of bacteria with SCs. This result suggests
the presence of a receptor-ligand recognition system
employed by S. pneumoniae for invasion of the SCs,
since incubation of the cell cultures with latex beads
Figure 1 Confocal microscopy images showing expression of the mannose receptor (MR) in uninfected and infected Schwann cells
(SCs) by Streptococcus pneumoniae. (A) Optical sections showing the expression of S100-β in infected Schwann cells (SCs) cultured from the
adult sciatic nerve. (B and C) Double immunolabeled images, showing in B, uninfected SCs labeled for S100-β in red (maximum nuclear diameter),
and in C, the same cells immunolabeled for the mannose receptor (cMR) conjugated with Alexa Fluor 488. The same field demonstrates that all S100-β+ cells
are also labeled with cMR (plane at or near the free surface of the membrane). (D) Optical section, where SCs infected by S. pneumoniae for 3 h were
immunolabeled for cMR (red). Bacteria were stained with DAPI (blue). Orthogonal z-sections in the horizontal and vertical planes reveal S.
pneumoniae adhered (arrow) or internalized (arrowheads) by SCs (D). The nuclei were counterstained with DAPI. These results are representative
of five separate experiments. Scale bar = 18 μm in (A); 18 μm in (B - C); 12 μm in (D).
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result in a change in the number of infected SCs (not
shown).
The reduction in the percentage of infected SCs after
12 and 24 h of association can also be attributed to a
phenomenon known as pneumococcal fratricide, which
causes the activation of LytA to disrupt completely the
cell wall of noncompetent bacteria. [37-39]. We hypoth-
esized that this fratricide phenomenon may also explain
why no differences were found between 3 and 24 h of
infection in mannan-treated cultures, since competitionof bacteria/mannan for binding sites on the cell surface
may have selected bacteria with different abilities to
cause infection prior to saturation of these sites. Similar
results were obtained in our previous studies on the
interaction of OECs with S. pneumoniae, indicating the
presence of a functional MR expressed on the OECs cel-
lular surface, which binds the capsule from bacteria in a
mannan-inhibitable manner [3].
Previous studies using animal models have shown that
the capsular polysaccharide might influence the propor-
tion of bacteria capable of adhering to and invading the
Figure 2 Kinetics of association (adhesion or internalization) of
Streptococcus pneumoniae with Schwann cells (SCs). The
percentage of SCs containing adhered or internalized S. pneumoniae
was quantified at different times up to 24 h. The graph shows a
progressive decrease in the number of S. pneumoniae associated
with the SCs. These data are representative of three separate
experiments, each of which was conducted in triplicate. ***P <0.0001.
For statistical analysis, we used Two-way ANOVA and Tukey’s Multiple
Comparison Test.
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formation may play an important role in pneumococcal
recognition [13]. Additionally, the MR was found to bind to
purified capsular polysaccharides of S. pneumoniae and to
the lipopolysaccharides, but not capsular polysaccharides, ofFigure 3 Competition assays showing the participation of
mannose receptor (MR) during the association of Streptococcus
pneumoniae with Schwann cells (SCs). The assays were performed
by adding increasing doses of mannan (10 to 1000 μg/ml) in the
interaction medium, and the results were highly statistically
significant (***P <0.0001) at a dose equal to or higher than 100 μg/ml.
The graph shows an inhibition of the percentage of SCs with associated
bacteria immediately after 3 h of association (black bar versus white
bar). However, this percentage was not significantly affected after this
time up to 24 h of infection in mannan-treated cultures (black
bar versus dark-gray bar). These data are representative of three
separate experiments, each of which was conducted in triplicate.
For statistical analysis, we used Two-way ANOVA and Tukey’s Multiple
Comparison Test.Klebsiella pneumoniae. However, no direct correlation can
be made between polysaccharide structures and recognition
by MR, since, although they were Ca2+-dependent and inhi-
bitable by D-mannose, these polysaccharides had none of
the structural features often associated with known MR
[13]. It may be possible that S. pneumoniae changes some
capsular structures after an initial contact of their mannosy-
lated residues with the MR of the host cell surface, and
hence may also interact with other non-lectin domains of
the receptor.
The morphology of the bacteria was analyzed by con-
focal microscopy. As might be expected, adhered bac-
teria were easily recognized by their uniform size,
smooth contour, and neat arrangement in diplococcus-
shaped pairs, similar to the appearance commonly ob-
served in bacterial cultures. There were no significant
morphological changes in the extracellular bacteria be-
fore or after the experiments.
Cytochemistry assays with Man/BSA-FITC binding
were performed in order to verify a possible colocaliza-
tion between a mannosylated ligand and internalized S.
pneumoniae. Similarly to the report in our previous
studies [20,7], incubation of uninfected SCs with Man/
BSA-FITC showed an intense labeling, widely distributed
on the cellular surface and also in the intracellular do-
main. However, this pattern was not significantly af-
fected by bacterial infection. For negative controls, the
same Man/BSA-FITC reactions performed in the pres-
ence of 250 mM D-mannose resulted in loss of the
Man/BSA-FITC labeling in SC tagged by anti-S100-β
antibody (not shown). S. pneumoniae was localized
predominantly in cytoplasmic compartments, with in-
tense staining for Man/BSA-FITC, presumably defin-
ing edges of the vesicles (Figure 4A, C and D). Only
small numbers of S. pneumoniae were bound to the SC
surface (Figure 4B). Moreover, the anti-pneumococcal
antiserum staining colocalized with the internalized
man/BSA-FITC, suggesting that both markers are present
within the same endocytic compartment of the SC
(Figure 4E).
Interestingly, incubation of the SCs with Man/BSA-
FITC resulted in a large number of intracellular S. pneu-
moniae cells with a nearly complete loss of the capsule
(Figure 4D). In addition, large numbers of S. pneumo-
niae internalized by SC in a nonencapsulated form were
observed after 3 h of infection, but no substantial loss of
bacterial viability was observed under these conditions
after washing and recovery of living bacteria from the
lysed cell host. Nevertheless, we cannot rule out this
possibility, since previous studies showed that during al-
veolar macrophage infection, significantly more intracel-
lular nonencapsulated S. pneumoniae were killed than
the capsulated form [41]. In fact, we observed a reduc-
tion in the number of infected cells immediately after
Figure 4 Confocal microscopy analysis of the mannosyl/bovine serum albumin-fluorescein isothiocyanate (man/BSA-FITC) colocalization with
Streptococcus pneumoniae capsule in Schwann cells (SC). (A) Optical section of infected Schwann cells cultured for 48 h, immunolabeled for
anti-pneumococcal antiserum (red) and reacted with Man/BSA-FITC (green). Active CTLDs of MR in infected SCs were observed after receptor-ligand
binding assays with Man/BSA-FITC (red, yellow and white dashed squares in A). Higher-magnification views of the red, yellow and white boxes in A
show details of S. pneumoniae adhered to the cellular surface (B) or internalized by SC in C and D. Internalized bacteria can be seen throughout the
cytoplasm of the SCs (thin arrows in C and D), some of which lack the polysaccharide capsule (thick arrow in D). (E) Optical section at the maximum
nuclei diameter of A with the orthogonal plane images cut at the yellow and red lines, and projected in the upper and right columns, respectively.
Orthogonal projections show colocalization of both markers (arrows). The nuclei of SCs and/or bacterial DNA (blue dots) are stained with
DAPI. The DAPI counterstaining shows the bacterial DNA surrounded by intense labeling of the pneumococcus capsule that reacted with
the anti-pneumococcal antiserum (B - D). These results are representative of five separate experiments. Scale bar = 30 μm in (A); 1.5 μm in
(B); 2 μm in (C - D); 18 μm in (E).
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different times up to 24 h. Several aspects may be asso-
ciated with this finding, including the ability of bacteria
to escape from endocytic vesicles and then migrate tothe extracellular environment [42], or die, either imme-
diately after the adhesion or during internalization [39].
However, continued studies are necessary to better
understand this mechanism in our model.
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Our study provided new insights into the molecular and
cellular mechanisms by which S. pneumoniae can gain
access to the CNS in the absence of bacteremia. The
nasopharynx and maxillary sinuses are richly innervated
by myelinated and non-myelinated sensory axons (and
their associated Schwann cells) from the trigeminal
nerve; thus, it can be predicted that any infection of SCs
in these regions could provide a means of transport for
S. pneumoniae toward the brain along the peripheral
nerves. Moreover, considering that S. pneumoniae is a
common commensal in the nasopharynx of healthy
adults and children, any surgical procedure in this region
could result in a risk of contamination. Actually, pneumo-
coccal meningitis may occur as a postoperative complica-
tion, due to invasion of multidrug-resistant S. pneumoniae
strains from the nasopharynx after simultaneous osteot-
omy of the cranium and facial bone in intracraniofacial
surgery [43]. Similarly, other nerves of the head may also
be important targets for infections, since pneumococcal
meningitis is more likely in patients who received cochlear
implantation through the surgical insertion technique in
proximity to the auditory nerve in the inner ear (cochlea).
Occasionally, in the presence of acute otitis media, it is
possible that S. pneumoniae can reach the CNS via the
auditory nerve [44].
In summary, our data offer novel evidence that SCs
could be essential for pneumococcal cells to escape
phagocytosis and killing by innate immune cells. On the
other hand, the results also support the idea of SCs as
immunocompetent cells of the PNS that can mediate an
efficient immune response against pathogens via MR.
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